Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms

• Published in: World journal of gastroenterology : WJG Vol. 27; no. 21; pp. 2895 - 2909
• Main Authors: Han, Deng, Li, Yuan-Liang, Zhou, Zhi-Wei, Yin, Fei, Chen, Jie, Liu, Fang, Shi, Yan-Fen, Wang, Wei, Zhang, Yu, Yu, Xian-Jun, Xu, Jian-Ming, Yang, Run-Xiang, Tian, Chao, Luo, Jie, Tan, Huang-Ying
• Format: Journal Article
• Language: English
• Published: Baishideng Publishing Group Inc 07.06.2021
• Subjects: Retrospective Study
• ISSN: 1007-9327; 2219-2840
• DOI: 10.3748/wjg.v27.i21.2895

BACKGROUNDPoorly differentiated gastric neuroendocrine neoplasms (PDGNENs) include gastric neuroendocrine carcinoma (NEC) and mixed adenoneuroendocrine carcinoma, which are highly malignant and rare tumors, and their incidence has increased over the past few decades. However, the clinicopathological features and outcomes of patients with PDGNENs have not been completely elucidated. AIMTo investigate the clinicopathological characteristics and prognostic factors of patients with PDGNENs. METHODSThe data from seven centers in China from March 2007 to November 2019 were analyzed retrospectively. RESULTSAmong the 232 patients with PDGNENs, 191 (82.3%) were male, with an average age of 62.83 ± 9.11 years. One hundred and thirteen (49.34%) of 229 patients had a stage III disease and 86 (37.55%) had stage IV disease. Three (1.58%) of 190 patients had no clinical symptoms, while 187 (98.42%) patients presented clinical symptoms. The tumors were mainly (89.17%) solitary and located in the upper third of the stomach (cardia and fundus of stomach: 115/215, 53.49%). Most lesions were ulcers (157/232, 67.67%), with an average diameter of 4.66 ± 2.77 cm. In terms of tumor invasion, the majority of tumors invaded the serosa (116/198, 58.58%). The median survival time of the 232 patients was 13.50 mo (7, 31 mo), and the overall 1-year, 3-year, and 5-year survival rates were 49%, 19%, and 5%, respectively. According to univariate analysis, tumor number, tumor diameter, gastric invasion status, American Joint Committee on Cancer (AJCC) stage, and distant metastasis status were prognostic factors for patients with PDGNENs. Multivariate analysis showed that tumor number, tumor diameter, AJCC stage, and distant metastasis status were independent prognostic factors for patients with PDGNENs. CONCLUSIONThe overall prognosis of patients with PDGNENs is poor. The outcomes of patients with a tumor diameter > 5 cm, multiple tumors, and stage IV tumors are worse than those of other patients.